Domino's Pizza (DPZ) Tops Q1 EPS by 75c, Revenues Beat; 'Withdraws 2-3 Year Outlook'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
S&P 500 slips after report on coronavirus drug trial
April 23, 2020 7:12 AM EDTBy Noel Randewich
(Reuters) - The S&P 500 ended marginally lower on Thursday after a report that an experimental antiviral drug for the coronavirus flopped in its first randomized clinical trial, denting optimism that the pandemic's impact on the labor market was nearing an end.
All three main U.S. stock indexes fell back from gains of over 1% after the Financial Times reported that a Chinese trial showed that Gilead Science's (NASDAQ: GILD) remdesivir did not improve patients' condition or reduce the pathogen's presence in the bloodstream.
Gilead said results from the... More
